Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of NNZ-2566 in Patients with Traumatic Brain Injury (TBI)
Sponsored by Neuren Pharmaceuticals (Australia)
$468K Funding
2 People
External
Related Topics
traumatic brain injury,
dose escalation,
nnz-2566,
clinical trial,
neurological treatment
People
Andrew Tang
Principal Investigator (PI)
Surgery
﹒Professor
Kurt Denninghoff
Co-Investigator (COI)
Dept of Emergency Medicine
﹒Professor
